U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07093489) titled 'Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)' on July 07.
Brief Summary: This is a health facility-based prospective test-negative (TND) case-control study to evaluate vaccine effectiveness and active safety monitoring (cohort event monitoring), and passive surveillance for evaluation of the safety of the LC16m8 mpox vaccine in individuals aged one year and older in the DRC.
This study aims to assess the LC16m8 vaccine effectiveness and safety. The following activities will be carried out:
* Community engagement
* Enhanced health facility-based mpox disease surveillance
...